# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-25-021287
Filing Date
2025-11-07
Accepted
2025-11-07 16:30:52
Documents
77
Period of Report
2025-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | form10-q.htm iXBRL | 10-Q | 1013200
2 | EX-31.1 | ex31-1.htm | EX-31.1 | 11905
3 | EX-31.2 | ex31-2.htm | EX-31.2 | 11900
4 | EX-32.1 | ex32-1.htm | EX-32.1 | 6784
5 | EX-32.2 | ex32-2.htm | EX-32.2 | 6777
6 | GRAPHIC | form10-q_001.jpg | GRAPHIC | 18991
| Complete submission text file | 0001493152-25-021287.txt |  | 6010838

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL SCHEMA FILE | erna-20250930.xsd | EX-101.SCH | 50874
8 | XBRL CALCULATION FILE | erna-20250930_cal.xml | EX-101.CAL | 73347
9 | XBRL DEFINITION FILE | erna-20250930_def.xml | EX-101.DEF | 203403
10 | XBRL LABEL FILE | erna-20250930_lab.xml | EX-101.LAB | 432186
11 | XBRL PRESENTATION FILE | erna-20250930_pre.xml | EX-101.PRE | 353968
79 | EXTRACTED XBRL INSTANCE DOCUMENT | form10-q_htm.xml | XML | 795872

Mailing Address 10531 4S COMMONS DRIVE SUITE 166-550 SAN DIEGO CA 92127
Business Address 1035 CAMBRIDGE STREET SUITE 18A CAMBRIDGE MA 02141 (617) 798-6700
Ernexa Therapeutics Inc. (Filer) CIK: 0000748592 (see all company filings)

EIN.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-11460 | Film No.: 251463102
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)